Anaphylaxis and toxic epidermal necrolysis or Stevens-Johnson syndrome after nonmucosal topical drug application: Fact or fiction?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 8, 2007, Pages 877-883

  Sachs, B ^a,b   Fischer Barth, W ^a   Erdmann, S ^b   Merk, H F ^b   Seebeck, J ^a  

^a FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Anaphylaxis; Drug allergy; Toxic epidermal necrolysis

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; ARSPHENAMINE; BACITRACIN; BENZYL ALCOHOL; BENZYL NICOTINATE; CAMPHOR; CAPSAICIN; CHLORHEXIDINE; CLIOQUINOL; DICLOFENAC; ESTRADIOL; FRAMYCETIN; GLYCOL SALICYLATE; HEPARIN; HISTAMINE; LIDOCAINE; MERBROMIN; NEBACETIN; NEOMYCIN; NICOBOXIL; NICOTINIC ACID METHYL ESTER; NONIVAMIDE; POLYMYXIN; POVIDONE; PROPANOL; STREPTOMYCIN; SULFADIAZINE; UNINDEXED DRUG;

ADULT; ANAPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; GERMANY; HUMAN; HYPERSENSITIVITY; MALE; MUCOSA; PRIORITY JOURNAL; RISK FACTOR; SKIN INJURY; STEVENS JOHNSON SYNDROME; SYSTEMIC CIRCULATION; TOXIC EPIDERMAL NECROLYSIS;

ADMINISTRATION, TOPICAL; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANAPHYLAXIS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; GERMANY; HUMANS; MALE; RISK FACTORS; STEVENS-JOHNSON SYNDROME; WOUNDS AND INJURIES;

EID: 34447136809     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01398.x     Document Type: Article

References (57)

1. Autegarden J-E, Pequet C, Huet S, Bayrou O, Leynadier F. Anaphylactic shock after application of chlorhexidine to unbroken skin. Contact Dermatitis 1999 40 : 215.
2. Erel F, Karaayvaz M, Deveci M, Ozangüc N. Severe anaphylaxis from rifamycin SV. Ann Allergy Asthma Immunol 1998 81 : 257 260.
3. Knwoles SR, Shear NH. Anaphylaxis from bacitracin and polymyxin B (Polysporin) ointment. Int J Dermatol 1995 34 : 572 573.
4. Proebstle TM, Jugert FK, Merk HF, Gall H. Severe anaphylactic reaction to topical administration of framycetin. J Allergy Clin Immunol 1995 96 : 429 430.
5. Schechter JF, Wilkinson RD, Del Caprio J. Anaphylaxis following the use of bacitracin ointment. Arch Dermatol 1984 120 : 909 911.
6. Roupe G, Strannegard Ö. Anaphylactic shock elicited by topical administration of Bacitracin. Arch Dermatol 1969 100 : 450 452.
7. Saryan JA, Dammin TC, Bouras AE. Anaphylaxis to topical bacitractin zinc ointment. Am J Emerg Med 1998 16 : 512 513.
8. Genvert GI, Cohen EJ, Donnenfeld ED, Blecher MH. Erythema multiforme after use of topical sulfacetamide. Am J Opthalmol 1985 99 : 465 468.
9. Gottschalk HR, Stone OJ. Stevens-Johnson syndrome form ophthalmic sulfonamide. Arch Dermatol 1976 112 : 513 514.
10. Newman JM, Rindler JM, Bergfeld WF, Brydon JK. Stevens-Johnson syndrome associated with a topical nitrogen mustard therapy. J Am Acad Dermatol 1997 36 : 112 114.
11. Praz SM, de Torrente A, Zender H, Schmied E, Schleppy CA, Genné D. Toxic epidermal necrolysis after topical intranasal application of Mupirocin. Infect Control Hosp Epidemiol 2003 24 : 459 460.
12. Rubin Z. Ophthalmic sulfonamide-induced Stevens-Johnson syndrome. Arch Dermatol 1977 113 : 235 236.
13. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000 356 : 1255 1259.
14. Mockenhaupt M. Schwere Arzneimittelreaktionen der Haut. Hautarzt 2005 56 : 24 31.
15. Johansson SGO, Bieber T, Dahl R et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol 2004 113 : 832 836.
16. Cardot E, Tillie-Leblond I, Jeannin P, Facon A, Breuil K, Patte F et al. Anaphylactic reaction to local administration of rifamycin SV. J Allergy Clin Immunol 1995 95 : 1 7.
17. Maucher OM. Anaphylaktische Reaktionen beim Epicutantest. Der Hautarzt 1972 23 : 139 140.
18. Comaish JS, Cunliffe WJ. Absorption of drugs form varicose ulcers: a cause of anaphylaxis. Br J Clin Pract 1967 21 : 97 98.
19. Selcow JE. Life threatening anaphylaxis following topical administration of bacitracin ointment: case report. NESA Proc. 1982 3 : 255 257.
20. Vale MA, Connolly A, Epstein AM, Vale MR. Bacitracin-induced anaphylaxis. Arch Dermatol 1978 114 : 800.
21. Mancuso G, Masara N. Contact urticaria and severe anaphylaxis from rifamycin SV. Contact Dermatitis 1992 27 : 124 125.
22. Piazza I. Anaphylactic reaction to local administration of rifamycin. Allergologie 1989 12 : 96 abstract).
23. Garcia F, Blanco J, Carretero P, Herrero D, Juste S, Garces M et al. Anaphylactic reactions to topical rifamycin. Allergy 1999 54 : 527 528.
24. Pippen R. Anaphylactoid reaction after Chymacort ointment. Br Med J 1966 7 : 1172.
25. Levene GM, Withers AFD. Anaphylaxis to streptomycin and hyposensitization (parasensitization). Trans St John's Hosp Derm Soc 1969 55 : 184 188.
26. Chzoo-Chen Y, Lin T-W, Sun C-C. Anaphylactic reaction to silver sulfadiazine topical application on a burn patient. J Surg Assoc ROC 1993 26 : 1937 1940.
27. Goh CL. Anaphylaxis from topical neomycin and bacitracin. Aust J Dermatol 1986 27 : 125 126.
28. Dyck ED, Vadas P. Anaphylaxis to topical bacitracin. Allergy 1997 52 : 870 871.
29. Eedy DJ, McMillan JC, Bingham EA. Anaphylactic reactions to topical antibiotic combinations. Postgrad Med J 1990 66 : 858 859.
30. Fox KA. Anaphylaxis caused by polymixin B sulfate and zinc bacitracin ointment. J Emerg Nurs 1994 20 : 262 264.
31. Palungwachira P. Contact urticaria syndrome and anaphylactoid reaction from topical clioquinol and bacitracin (Banocin): a case report. J Med Assoc Thai 1991 74 : 43 46.
32. Sikorski H. Salvarsan-Allergie der Haut. Z Haut Geschlechtskr 1951 11 : 341 345.
33. Conraads VMA, Jorens PG, Ebo DG, Claeys MJ, Bosmans JM, Vrints CJ. Coronary artery spasm complicating anaphylaxis secondary to skin disinfectant. Chest 1998 113 : 1417 1419.
34. Evans RJ. Acute anaphylaxis due to topical chlorhexidine acetate. BMJ 1992 304 : 686.
35. Krautheim AB, Jermann THM, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis 2004 50 : 113 116.
36. Okano M, Nomura M, Hata S, Okada N, Sato K, Kitano Y et al. Anaphylactic symptoms due to chlorhexidine gluconate. Arch Dermatol 1989 125 : 50 52.
37. Peutrell JM. Anaphylactoid reaction to topical chlorhexidine during anaesthesia. Anaesthesia 1992 47 : 1013.
38. Snellman E, Rantanen T. Severe anaphylaxis after a chlorhexidine bath. JAAD 1999 40 : 771 772.
39. Torricelli R, Wütherich B. Life-threatening anaphylactic shock due to skin application of chlorhexidine. Clin Exp Allergy 1996 26 : 112.
40. Olivieri J, Eigenmann PA, Hauser C. Severe anaphylaxis to a new disinfectant: polyhexanide, a chlorhexidine polymer. Schweiz Med Wochenschr 1998 128 : 1508 1511.
41. Pedrosa C, Costa H, Oliveira G, Romariz J, Praca F. Anaphylaxis to povidone in a child. Pediatr Allergy Immunol 2005 16 : 361 362.
42. Kleinhans D, Zwißler H. Anaphylaktischer Schock nach Anwendung einer Benzocain-haltigen Salbe. Z Hautkr 1980 55 : 945 947.
43. Grunnet E. Contact urticaria and anaphylactoid reaction induced by topical application of nitrogen mustard. Brit J Dermatol 1976 94 : 101 103.
44. Daughters D, Zackheim H, Maibach H. Urticaria and anaphylactoid reactions after topical application of mechlorethamine. Arch Dermatol 1973 107 : 429 430.
45. Werfel T, Neumann C. Anaphylaktische Reaktion auf extern appliziertes Bufexamac. Allergologie 1988 17 : 34 (abstract).
46. Lückerath I, Steigleder GK. Nachweis von Allergien gegen Arzneien durch Hauttests. In : Werner M, Ruppert V editors. Praktische Allergiediagnostik. Methoden des direkten Allergennachweises, 3rd edn. Stuttgart : Thieme, 1979 : 89 101.
47. Culver CA, Malina JJ, Talbert RL. Probable anaphylactoid reaction to a pyrethin pediculocide Shampoo. Clin Pharm 1988 7 : 846 849.
48. Schiavino D, Nuccera E, Murzilli F, Papa G, Fais G, Patriarca G et al. Case report: anaphylactic shock after skin test with phytohaemoagglutinin. Allergy 1992 47 : 121 122.
49. Mozelsio NB, Harris KE, McGrath KG, Grammer LC. Immediate systemic hypersensitivity reaction associated with topical application of Australian tea tree oil. Allergy Asthma Proc 2003 24 : 73 75.
50. Tadokoro K, Ohtoshi T, Takafuji S, Nakajima K, Suzuki S, Yamamoto K et al. Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studies. J Allergy Clin Immunol 1991 88 : 620 629.
51. Babilas P, Landthaler M, Szeimies RM. Anaphylaktische Reaktion nach Kontakt zu Haarbleichmittel. Hautarzt 2005 56 : 1152 1155.
52. Fisher AA. Urticaria, asthma, and anaphylaxis due to sodium sulfite in an antifungal creme complicated by treatment with aminophylline in an ethylenediamine-sensitive person. Part I. Cutis 1989 44 : 19 20.
53. Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P et al. Toxic epidermal necrolysis. Effector cells are drug-specific cytotoxic cells. J Allergy Clin Immunol 2004 114 : 1209 1215.
54. Demoly P, Hillaire-Buys D. Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am 2004 24 : 345 356.
55. Leone R, Venegoni M, Motola D, Moretti U, Piazetta V, Cocci A et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials. Drug Saf 2003 26 : 109 120.
56. Leone R, Conforti A, Venegoni M, Motola D, Moretti U, Meneghelli I et al. Drug- induced anaphylaxis. Drug Saf 2005 28 : 547 556.
57. International Collaborative Study of Severe Anaphylaxis. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003 12 : 195 202.